Prange Group and its affiliate Adragos Pharma signed definitive agreements with Fresenius Kabi to acquire a sterile pharmaceutical production site in Halden, Norway. As part of the transaction, Fresenius Kabi will strike  a long-term supply agreement for products manufactured at the Halden site. The acquisition marks a milestone for both the Prange Group and Adragos Pharma expanding their global presence and adding significant capacity for sterile liquid manufacturing.  According to the compa...